The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130036007 · Cited by 2,071
Petersen, P., Godtfredsen, J., Boysen, G., Andersen, E., & Andersen, B. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91200-2 · Cited by 1,820
EAFT (European Atrial Fibrillation Trial) Study Group (1993) · The Lancet · doi:10.1016/0140-6736(93)92358-z · Cited by 1,741
Stroke Prevention in Atrial Fibrillation Study. Final results.
(1991) · Circulation · doi:10.1161/01.cir.84.2.527 · Cited by 1,696
(1990) · New England Journal of Medicine · doi:10.1056/nejm199011293232201 · Cited by 1,530
The management of thrombosis in the antiphospholipid-antibody syndrome
Khamashta, M. A., Cuadrado, M. J., Mujic, F., Taub, N. A., Hunt, B. J., & Hughes, G. R. V. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504133321504 · Cited by 1,450
Palareti, G., Leali, N., Coccheri, S., Poggi, M., Manotti, C., D'Angelo, A., Pengo, V., Erba, N., Moia, M., Ciavarella, N., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)01109-9 · Cited by 1,333
Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone
Hauschka, P. V., Lian, J. B., Cole, D. E., & Gundberg, C. M. (1989) · Physiological Reviews · doi:10.1152/physrev.1989.69.3.990 · Cited by 1,272
Aithal, G. P., Day, C. P., Kesteven, P. J., & Daly, A. K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)04474-2 · Cited by 1,243
Hemorrhagic Complications of Anticoagulant Treatment
Levine, M. N., Raskob, G., Landefeld, S., & Kearon, C. (2001) · Chest · doi:10.1378/chest.119.1_suppl.108s · Cited by 1,134
Weitz, J. I., Hudoba, M., Massel, D., Maraganore, J., & Hirsh, J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114723 · Cited by 1,123
Self-citationCanadian atrial fibrillation anticoaguiation (CAFA) study
Connolly, S. J., Laupacis, A., Gent, M., Roberts, R. S., Cairns, J. A., & Joyner, C. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90585-w · Cited by 1,111
Kearon, C., Gent, M., Hirsh, J., Weitz, J., Kovacs, M. J., Anderson, D. R., Turpie, A. G., Green, D., Ginsberg, J. S., Wells, P., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903253401201 · Cited by 1,072
Self-citationWarfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
(1993) · New England Journal of Medicine · doi:10.1056/nejm199301143280227 · Cited by 1,067
Maternal and fetal sequelae of anticoagulation during pregnancy
Hall, J. G., Pauli, R. M., & Wilson, K. M. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90181-3 · Cited by 997
Lipowski, Z. J. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92478-7 · Cited by 944
Schulman, S., Rhedin, A.-S., Lindmarker, P., Carlsson, A., Lärfars, G., Nicol, P., Loogna, E., Svensson, E., Ljungberg, B., Walter, H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506223322501 · Cited by 932
Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin
Hylek, E. M., & Singer, D. E. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-11-199406010-00001 · Cited by 919
Optimal Oral Anticoagulant Therapy in Patients with Mechanical Heart Valves
Cannegieter, S. C., Rosendaal, F. R., Wintzen, A. R., van der Meer, F. J. M., Vandenbroucke, J. P., & Briet, E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507063330103 · Cited by 908
Roth, G. J., & Majerus, P. W. (1975) · Journal of Clinical Investigation · doi:10.1172/jci108132 · Cited by 861
Management of Anticoagulation before and after Elective Surgery
Kearon, C., & Hirsh, J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705223362107 · Cited by 812
Self-citationHylek, E. M., Skates, S. J., Sheehan, M. A., & Singer, D. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608223350802 · Cited by 789
Bern, M. M., Lokich, J. J., Wallach, S. R., Bothe, A., Benotti, P. N., Arkin, C. F., Greco, F. A., Huberman, M., & Moore, C. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-3-112-6-423 · Cited by 788
Landefeld, C. S., & Goldman, L. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90564-0 · Cited by 778
Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis
Hull, R., Hirsh, J., Jay, R., Carter, C., England, C., Gent, M., Turpie, A. G. G., McLoughlin, D., Dodd, P., Thomas, M., et al. (1982) · New England Journal of Medicine · doi:10.1056/nejm198212303072704 · Cited by 728
Self-citationAntiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients
Rosove, M. H., & Brewer, P. M. C. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-4-303 · Cited by 700
Risk Factors for Complications of Chronic Anticoagulation: A Multicenter Study
Fihn, S. D., McDonell, M., Martin, D., Henikoff, J., Vermes, D., Kent, D., White, R. H., & for the Warfarin Optimized Outpatient Follow-up Study Group* (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-7-199304010-00005 · Cited by 671
PREVENTION OF VENOUS THROMBOSIS AND PULMONARY EMBOLISM IN INJURED PATIENTS
Sevitt, S., & Gallagher, N. G. (1959) · The Lancet · doi:10.1016/s0140-6736(59)91464-3 · Cited by 651
The Effect of Warfarin on Mortality and Reinfarction after Myocardial Infarction
Smith, P., Arnesen, H., & Holme, I. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007193230302 · Cited by 638
STROKEPREVENTIONINATRIALFIBRIL (1994) · The Lancet · doi:10.1016/s0140-6736(94)91577-6 · Cited by 621
Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis
Hull, R., Delmore, T., Genton, E., Hirsh, J., Gent, M., Sackett, D., McLoughlin, D., & Armstrong, P. (1979) · New England Journal of Medicine · doi:10.1056/nejm197910183011602 · Cited by 604
Self-citationThe Duration of Oral Anticoagulant Therapy after a Second Episode of Venous Thromboembolism
Schulman, S., Granqvist, S., Holmström, M., Carlsson, A., Lindmarker, P., Nicol, P., Eklund, S.-G., Nordlander, S., Lärfars, G., Leijd, B., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702063360601 · Cited by 604
Chiquette, E., Amato, M. G., & Bussey, H. I. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.15.1641 · Cited by 596
Self-citationNEED FOR LONG-TERM ANTICOAGULANT TREATMENT IN SYMPTOMATIC CALF-VEIN THROMBOSIS
LAGERSTEDT, C. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90459-3 · Cited by 569
O'Neill, D. D., Westerman, D. P., & Sacco, W. (1966) · doi:10.21236/ad0635168 · Cited by 566
A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve Replacement
Turpie, A., Gent, M., Laupacis, A., Latour, Y., Gunstensen, J., Basile, F., Klimek, M., & Hirsh, J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308193290802 · Cited by 547
Self-citation(1997) · ACC Current Journal Review · doi:10.1016/s1062-1458(97)83303-x · Cited by 539
Bleeding complications in oral anticoagulant therapy. An analysis of risk factors
van der Meer, F. J. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.13.1557 · Cited by 538
Interactions of Warfarin with Drugs and Food
Wells, P. S., Holbrook, A. M., Crowther, N. R., & Hirsh, J. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-9-199411010-00009 · Cited by 536
Self-citationThe Mode of Action of Vitamin K
Nelsestuen, G. L., Zytkovicz, T. H., & Howard, J. B. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)42259-x · Cited by 528
Levine, M., Hirsh, J., Arnold, A., Gent, M., Levine, M., Arnold, A., Bramwell, V., Pritchard, K. I., Stewart, D., Warr, D., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90008-6 · Cited by 510
Self-citationHeparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous Thrombosis
Hull, R. D., Raskob, G. E., Rosenbloom, D., Panju, A. A., Brill-Edwards, P., Ginsberg, J. S., Hirsh, J., Martin, G. J., & Green, D. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005033221802 · Cited by 505
Self-citationSchulman, S., Svenungsson, E., & Granqvist, S. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00060-6 · Cited by 497
(1997) · Annals of Neurology · doi:10.1002/ana.410420606 · Cited by 480
Hull, R. D., Raskob, G. E., Pineo, G. F., Rosenbloom, D., Evans, W. E., Mallory, T. H., Anquist, K., Smith, F., Hughes, G. W., Green, D., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311043291902 · Cited by 440
Adjusted Subcutaneous Heparin versus Warfarin Sodium in the Long-Term Treatment of Venous Thrombosis
Hull, R., Delmore, T., Carter, C., Hirsh, J., Genton, E., Gent, M., Turpie, G., & McLaughlin, D. (1982) · New England Journal of Medicine · doi:10.1056/nejm198201283060401 · Cited by 436
Self-citationMechanism of coumarin action: significance of vitamin K epoxide reductase inhibition
Whitlon, D. S., Sadowski, J. A., & Suttie, J. W. (1978) · Biochemistry · doi:10.1021/bi00601a003 · Cited by 384
Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation
Hylek, E. M. (1998) · JAMA · doi:10.1001/jama.279.9.657 · Cited by 378
The Prophylactic Portacaval Shunt
(1972) · The Lancet · doi:10.1016/s0140-6736(72)91163-4 · Cited by 373
Trial of Different Intensities of Anticoagulation in Patients with Prosthetic Heart Valves
Saour, J. N., Sieck, J. O., Mamo, L. A. R., & Gallus, A. S. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002153220703 · Cited by 368
Comparison of 5-mg and 10-mg Loading Doses in Initiation of Warfarin Therapy
Harrison, L., Johnston, M., Massicotte, M. P., Crowther, M., Moffat, K., & Hirsh, J. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-2-199701150-00006 · Cited by 359
Self-citationTurpie, A. G. G., Hirsh, J., Gunstensen, J., Nelson, H., & Gent, M. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92070-3 · Cited by 315
Self-citationOral Anticoagulant Therapy in Patients With Coronary Artery Disease: A Meta-analysis
Anand, S. S. (1999) · JAMA · doi:10.1001/jama.282.21.2058 · Cited by 311
Gallus, A., Tillett, J., Jackaman, J., Mills, W., & Wycherley, A. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91431-5 · Cited by 305
Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction
(1997) · The Lancet · doi:10.1016/s0140-6736(97)01180-x · Cited by 301
Calibration of Reference Thromboplastins and Standardisation of the Prothrombin Time Ratio
Kirkwood, T. B. L. (1983) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657371 · Cited by 300
Chesebro, J. H., Fuster, V., Elveback, L. R., McGoon, D. C., Pluth, J. R., Puga, F. J., Wallace, R. B., Danielson, G. K., Orszulak, T. A., Piehler, J. M., et al. (1983) · The American Journal of Cardiology · doi:10.1016/0002-9149(83)90673-2 · Cited by 300
Temporary Discontinuation of Warfarin Therapy: Changes in the International Normalized Ratio
White, R. H., McKittrick, T., Hutchinson, R., & Twitchell, J. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-1-199501010-00006 · Cited by 280
Gitter, M. J., Jaeger, T. M., Petterson, T. M., Gersh, B. J., & Silverstein, M. D. (1995) · Mayo Clinic Proceedings · doi:10.4065/70.8.725 · Cited by 276
Antithrombotic agents in coronary artery disease
Resnekov, L., Chediak, J., Hirsh, J., & Lewis, H. D. (1989) · Chest · doi:10.1378/chest.95.2.52s · Cited by 263
Self-citationPharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man
Breckenridge, A., Orme, M., Wesseling, H., Lewis, R. J., & Gibbons, R. (1974) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1974154424 · Cited by 261
Francis, C. W. (1983) · JAMA · doi:10.1001/jama.1983.03330270038029 · Cited by 256
GRAHAM, D. Y., & SMITH, J. L. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-3-390 · Cited by 233
Aging and the Anticoagulant Response to Warfarin Therapy
Gurwitz, J. H., Avorn, J., Ross-Degnan, D., Choodnovskiy, I., & Ansell, J. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-11-901 · Cited by 231
Self-citationMonitoring Warfarin Therapy in Patients with Lupus Anticoagulants
Moll, S., & Ortel, T. L. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-3-199708010-00001 · Cited by 214
Powers, P. J. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390040013003 · Cited by 214
Studies on the optical enantiomorphs of warfarin in man
Reilly, R. A. O. (1974) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1974162348 · Cited by 213
Landefeld, C. S., Rosenblatt, M. W., & Goldman, L. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90565-2 · Cited by 211
The Stereoselective Interaction of Warfarin and Metronidazole in Man
O'Reilly, R. A. (1976) · New England Journal of Medicine · doi:10.1056/nejm197608122950702 · Cited by 209
Jorgensen, M. J., Cantor, A. B., Furie, B. C., Brown, C. L., Shoemaker, C. B., & Furie, B. (1987) · Cell · doi:10.1016/0092-8674(87)90422-3 · Cited by 205
Congenital malformations associated with the administration of oral anticoagulants during pregnancy
Lietman, P. S., Pettifor, J. M., & Benson, R. (1975) · The Journal of Pediatrics · doi:10.1016/s0022-3476(75)80986-3 · Cited by 204
Assessment of Short-term Anticoagulant Administration after Cardiac Infarction
(1969) · BMJ · doi:10.1136/bmj.1.5640.335 · Cited by 200
Protein C and the Development of Skin Necrosis During Anticoagulant Therapy
Broekmans, A. W., Bertina, R. M., Loeliger, E. A., Hofmann, V, & Klingemann, H.-G. (1983) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657378 · Cited by 199
Role of Vitamin-K-Dependent Proteins in Bone Metabolism
Price, P. A. (1988) · Annual Review of Nutrition · doi:10.1146/annurev.nu.08.070188.003025 · Cited by 196
Guidelines for prevention of thromboembolic events in valvular heart disease
Gohlke-Bärwolf, C., Acar, J., Oakley, C., Butchart, E., Burckhardt, D., Bodnar, E., Hall, R., Delahaye, J.-P., Horstkotte, D., Krémer, R., et al. (1995) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060739 · Cited by 186
Atrial fibrillation and stroke. Three new studies, three remaining questions
Albers, G. W. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.13.1443 · Cited by 182
Drug Interactions with Coumarin Anticoagulants
Koch-Weser, J., & Sellers, E. M. (1971) · New England Journal of Medicine · doi:10.1056/nejm197109022851005 · Cited by 180
Long-term Patient Self-management of Oral Anticoagulation
Ansell, J. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.20.2185 · Cited by 176
Self-citationPoller, L., McKernan, A., Thomson, J. M., Elstein, M., Hirsch, P. J., & Jones, J. B. (1987) · BMJ · doi:10.1136/bmj.295.6609.1309 · Cited by 168
Self-citationLong-term Use of Oral Anticoagulants and the Risk of Fracture
Caraballo, P. J., Heit, J. A., Atkinson, E. J., Silverstein, M. D., O'Fallon, W. M., Castro, M. R., & Melton, L. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.15.1750 · Cited by 159
Anticoagulants in acute myocardial infarction. Results of a cooperative clinical trial
Ebert, R. V. (1973) · JAMA · doi:10.1001/jama.225.7.724 · Cited by 159
Mok, C. K., Boey, J. Y., Wang, R., Chan, T. K., Cheung, K. L., Lee, P. K., Chow, J. S. F., Ng, R. P., & Tse, T.-F. (1985) · Circulation · doi:10.1161/01.cir.72.5.1059 · Cited by 156
Effect of 3.2%vs3.8% Sodium Citrate Concentration on Routine Coagulation Testing
Adcock, D. M., Kressin, D. C., & Marlar, R. A. (1997) · American Journal of Clinical Pathology · doi:10.1093/ajcp/107.1.105 · Cited by 155
Tweedle, D. E. F. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92190-5 · Cited by 155
Ansell, J., & Hughes, R. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90040-x · Cited by 151
Self-citationPREVENTION OF VENOUS THROMBOSIS AND PULMONARY EMBOLISM IN INJURED PATIENTS
Sevitt, S. (1962) · The Lancet · doi:10.1016/s0140-6736(62)92460-1 · Cited by 149
Is warfarin sodium contraindicated in the lactating mother?
McKenna, R., Cole, E. R., & Vasan, U. (1983) · The Journal of Pediatrics · doi:10.1016/s0022-3476(83)80378-3 · Cited by 145
Vitamin K deficiency from dietary vitamin K restriction in humans
Suttie, J., Mummah-Schendel, L. L., Shah, D. V., Lyle, B., & Greger, J. (1988) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/47.3.475 · Cited by 144
The warfarin-sulfinpyrazone interaction: stereochemical considerations
Toon, S., Low, L. K., Gibaldi, M., Trager, W. F., O’Reilly, R. A., Motley, C. H., & Goulart, D. A. (1986) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1986.3 · Cited by 144
Maillard, C., Berruyer, M., Serre, C., DECHAVANNE, M., & Delmas, P. D. (1992) · Endocrinology · doi:10.1210/endo.130.3.1531628 · Cited by 139
Flier, J. S., Underhill, L. H., Wessler, S., & Gitel, S. N. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409063111007 · Cited by 138
O’Reilly, R. A., Aggeler, P. M., Hoag, M. S., Leong, L. S., & Kropatkin, M. (1964) · New England Journal of Medicine · doi:10.1056/nejm196410152711602 · Cited by 135
Drapkin, A. (1972) · JAMA · doi:10.1001/jama.222.5.541 · Cited by 134
Minar, E., Hirschl, M., Bialonczyk, C., Stain, M., Mannhalter, C., Stümpflen, A., Schneider, B., Lechner, K., Kyrle, P. A., & Eichinger, S. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614409 · Cited by 131
The kinetics of activation of normal and gamma-carboxyglutamic acid-deficient prothrombins.
Malhotra, O. P., Nesheim, M. E., & Mann, K. G. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89728-9 · Cited by 130
Stereoselective Interaction of Omeprazole with Warfarin in Healthy Men
Sutfin, T. A., Balmér, K. C., Boström, H., Eriksson, S. A., Höglund, P., & Paulsen, O. (1989) · Therapeutic Drug Monitoring · doi:10.1097/00007691-198903000-00010 · Cited by 124
Correction of Excessive Anticoagulation with Low-Dose Oral Vitamin K1
Weibert, R. T., Le, D. T., Kayser, S. R., & Rapaport, S. I. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-12-199706150-00005 · Cited by 122
Prospective comparative study of computer programs used for management of warfarin.
Poller, L., Wright, D., & Rowlands, M. (1993) · Journal of Clinical Pathology · doi:10.1136/jcp.46.4.299 · Cited by 118
Self-citationConsensus Guidelines for Coordinated Outpatient Oral Anticoagulation Therapy Management
Ansell, J., Buttaro, M. L., Thomas, O. V., Knowlton, C. H., & Anticoagulation Guidelines Task Force (1997) · Annals of Pharmacotherapy · doi:10.1177/106002809703100516 · Cited by 117
Self-citationPalareti, G., Manotti, C., D’Angelo, A., Pengo, V., Erba, N., Moia, M., CIAVARELLA, N., Devoto, G., Berrettini, M., Leali, N., et al. (1997) · PubMed · Cited by 115
Friedman, R. J., Davidson, B. L., Heit, J. A., Kessler, C. M., Elliott, C. G., Cabanas, V., Chenault, C. S., Dall, D. M., CHANDLER, D. R., Drennan, D. B., et al. (1994) · Cited by 112
Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans
O’Reilly, R. A., Trager, W. F., Rettie, A. E., & Goulart, D. A. (1987) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1987.149 · Cited by 108
O’Reilly, R. A. (1980) · New England Journal of Medicine · doi:10.1056/nejm198001033020106 · Cited by 108
A Review of Enzyme Induction of Warfarin Metabolism with Recommendations for Patient Management
Cropp, J. S., & Bussey, H. I. (1997) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1997.tb03782.x · Cited by 108
Self-citationAntithrombotic Therapy for Cerebrovascular Disorders
Sherman, D. G., Dyken, M. L., Fisher, M., Gent, M., Harrison, M. J., & Hart, R. G. (1992) · CHEST Journal · doi:10.1378/chest.102.4_supplement.529s · Cited by 107
A mutation in the propeptide of Factor IX leads to warfarin sensitivity by a novel mechanism.
Chu, K. C., Wu, S. M., Stanley, T. E., Stafford, D. W., & High, K. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118956 · Cited by 106
Effective reversal of warfarin-induced excessive anticoagulation with low dose vitamin K1.
Shetty, H. G. M., Backhouse, G., Bentley, D. P., et al. (1992) · PubMed · Cited by 106
Stroke prevention in nonvalvular atrial fibrillation: A review of prospective randomized trials
Albers, G. W., Sherman, D. G., Gress, D. R., Paulseth, J. E., & Petersen, P. (1991) · Annals of Neurology · doi:10.1002/ana.410300402 · Cited by 101
Oldenburg, J., Quenzel, E., Harbrecht, U., Fregin, A., Kreß, W., Müller, C. R., Hertfelder, H.-J., Schwaab, R., Brackmann, H., & Hanfland, P. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.2213036.x · Cited by 96
Accuracy of Laboratory and Portable Monitor International Normalized Ratio Determinations
Kaatz, S. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.17.1861 · Cited by 92
Questions and Answers on Prothrombin Time Standardisation in Oral Anticoagulant Control
Loeliger, E. A., Poller, L., Samama, M. M., et al. (1985) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657886 · Cited by 86
Self-citationPlasma disposition of vitamin K1 in relation to anticoagulant poisoning.
Park, B. K., Scott, A., Wilson, A., Haynes, B., & Breckenridge, A. (1984) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1984.tb02526.x · Cited by 85
Accuracy and Precision of a Portable Anticoagulation Monitor in a Clinical Setting
McCurdy, S. A. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.3.589 · Cited by 81
Reversal of excessive effect of regular anticoagulation
Pengo, V., Banzato, A., Garelli, E., Zasso, A., & Biasiolo, A. (1993) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199304050-00010 · Cited by 80
Deep venous thrombosis and lupus anticoagulant. A case-control study.
Simioni, P., Prandoni, P., Zanon, E., Saracino, M. A., Scudeller, A., Villalta, S., Scarano, L., Girolami, B., Benedetti, L., & Girolami, A. (1996) · PubMed · Cited by 80
Resistance to Warfarin Due to Unrecognized Vitamin K Supplementation
O’Reilly, R. A., & Rytand, D. A. (1980) · New England Journal of Medicine · doi:10.1056/nejm198007173030317 · Cited by 80
Antithrombotic Therapy for Cerebrovascular Disorders
Sherman, D. G., Dyken, M. L., Gent, M., Harrison, M. J., Hart, R. G., & Mohr, J. P. (1995) · CHEST Journal · doi:10.1378/chest.108.4_supplement.444s · Cited by 79
Warfarin Resistance Caused by Broccoli
Kempin, S. J. (1983) · New England Journal of Medicine · doi:10.1056/nejm198305193082016 · Cited by 78
The Optimal Duration of Anticoagulant Therapy for Venous Thrombosis
Hirsh, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506223322510 · Cited by 76
Self-citationInteraction of Chronic Daily Warfarin Therapy and Rifampin
O’Reilly, R. A. (1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-83-4-506 · Cited by 75
Fairweather, R. B., Ansell, J., van den Besselaar, A. M. H. P., Brandt, J. T., Bussey, H. I., Poller, L., Triplett, D. A., & White, R. H. R. (1998) · PubMed · Cited by 72
Self-citationAnticardiolipin Antibodies and Recurrent Thromboembolism
Rance, A., Emmerich, J., & Fiessinger, J. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1655939 · Cited by 70
Deep Venous Thrombosis and Lupus Anticoagulant
Simioni, P., Prandoni, P., Zanon, E., Saracino, M. A., Scudeller, A., Villalta, S., Scarano, L., Girolami, B., Benedetti, L., & Girolami, A. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650551 · Cited by 66
Prophylaxis of thromboembolism in pregnancy: an alternative
Lao, T. T. H., de Swiet, M., Letsky, E. A., & Walters, B. N. J. (1985) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1985.tb01082.x · Cited by 62
Is the Dose of Warfarin Prescribed by American Physicians Unnecessarily High?
Hirsh, J. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370040151026 · Cited by 60
Self-citationThe Effects of Acetaminophen on Pharmacokinetics and Pharmacodynamics of Warfarin
Kwan, D., Bartle, W. R., & Walker, S. E. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/00912709922007570 · Cited by 60
D’Angelo, A., Seveso, M. P., D’Angelo, S. V., Gilardoni, F., Macagni, A., Manotti, C., & Bonini, P. A. (1989) · American Journal of Clinical Pathology · doi:10.1093/ajcp/92.3.321 · Cited by 60
Ageno, W., & Turpie, A. G. G. (1998) · Thrombosis Research · doi:10.1016/s0049-3848(98)00092-9 · Cited by 59
Effect of Sodium Dextrothyroxine in Patients Receiving Anticoagulants
Owens, J. C., Neely, W. B., & Owen, W. R. (1962) · New England Journal of Medicine · doi:10.1056/nejm196201112660205 · Cited by 59
Warfarin Metabolism and Drug-Drug Interactions
O’Reilly, R. A. (1987) · Springer eBooks · doi:10.1007/978-1-4757-5985-3_18 · Cited by 57
INTERACTION OF IBUPROFEN AND WARFARIN ON PRIMARY HAEMOSTASIS
Schulman, S., & Henriksson, K. G. (1989) · Rheumatology · doi:10.1093/rheumatology/28.1.46 · Cited by 54
Jennings, I., Luddington, R. J., & Baglin, T. P. (1991) · Journal of Clinical Pathology · doi:10.1136/jcp.44.11.950 · Cited by 53
Effect of erythromycin in patients receiving long-term warfarin therapy.
Weibert, R. T., Lorentz, S., Townsend, R. J., Cook, C. E., Klauber, M. R., & Jagger, P. I. (1989) · PubMed · Cited by 52
Valle, P. D., Crippa, L., Safa, O., Tomassini, L., Pattarini, E., Vigano’D’Angelo, S., Sabbadini, M. G., & D’Angelo, A. (1996) · PubMed · Cited by 46
Genetic control of anticoagulation
Mannucci, P. M. (1999) · The Lancet · doi:10.1016/s0140-6736(98)00326-2 · Cited by 46
Cosgriff, S. W. (1956) · Annals of Internal Medicine · doi:10.7326/0003-4819-45-1-14 · Cited by 44
Lack of Effect of Fortified Wine Ingested During Fasting and Anticoagulant Therapy
O’Reilly, R. A. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.141.4.458 · Cited by 42
Low-dose warfarin and low-dose aspirin in the primary prevention of ischemic heart disease
Meade, T. W. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90108-d · Cited by 40
HEREDITARY RESISTANCE TO COUMARIN ANTICOAGULANT DRUGS IN MAN AND RAT*
O’Reilly, R. A., Pool, J. G., & Aggeler, P. M. (1968) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1968.tb11950.x · Cited by 39
Thrombosis in the Antiphospholipid-Antibody Syndrome
Violi, F., Ferro, D., & Valesini, G. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509073331016 · Cited by 37
Studies on the Interaction of Warfarin and Clofibrate in Man
O’Reilly, R. A., Sahud, M. A., & ROBINSON, A. J. (1972) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649370 · Cited by 37
Interaction of secobarbital with warfarin pseudoracemates
O’Reilly, R. A., Trager, W. F., Motley, C. H., & Howald, W. N. (1980) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1980.149 · Cited by 33
Poller, L., MacCallum, P. K., THOMSON, J. M., & Kerns, W. (1990) · Heart · doi:10.1136/hrt.63.4.231 · Cited by 31
Self-citationMungall, D. R., & White, R. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-10-878 · Cited by 29
Oral anticoagulant in patients surviving myocardial infarction
Leizorovicz, A., & Boissel, J. P. (1983) · European Journal of Clinical Pharmacology · doi:10.1007/bf00610050 · Cited by 28
Anticoagulation and atrial fibrillation
Diener, C. (2010) · Schweizer Archiv für Neurologie und Psychiatrie · doi:10.4414/sanp.2010.02182 · Cited by 27
Comparison of thromboplastins using the ISI and INR system
Moriarty, H., Lam-Po-Tang, P. R. L. C., & Anastas, N. (1990) · Pathology · doi:10.3109/00313029009063783 · Cited by 23
Monitoring effects of oral anticoagulants during treatment with heparin.
Thomas, P. S., Fennerty, A. G., Backhouse, G., Bentley, D. P., Campbell, I. A., & Routledge, P. (1984) · BMJ · doi:10.1136/bmj.288.6412.191 · Cited by 22
Potentiation of warfarin anticoagulation by topical testosterone ointment.
Sm, L., & Weibert, R. T. (1985) · PubMed · Cited by 15
Laboratory Monitoring of Oral Anticoagulant Therapy
Poller, L., & Samama, M. M. (1994) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30358-5 · Cited by 12
Self-citation
Cited by
Pharmacology and Management of the Vitamin K Antagonists
Ansell, J., Hirsh, J., Hylek, E., Jacobson, A., Crowther, M., & Palareti, G. (2008) · Chest · doi:10.1378/chest.08-0670 · Cited by 2,118
Self-citationThe Pharmacology and Management of the Vitamin K Antagonists
Ansell, J., Hirsh, J., Poller, L., Bussey, H., Jacobson, A., & Hylek, E. (2004) · Chest · doi:10.1378/chest.126.3_suppl.204s · Cited by 1,528
Self-citationPalareti, G., Leali, N., Coccheri, S., Poggi, M., Manotti, C., D'Angelo, A., Pengo, V., Erba, N., Moia, M., Ciavarella, N., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)01109-9 · Cited by 1,333
Systematic overview of warfarin and its drug and food interactions
Holbrook, A. M. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.10.1095 · Cited by 1,160
Metadata
- Authors
- Hirsh, J., Dalen, J. E., Anderson, D. R., Poller, L., Bussey, H., Ansell, J., & Deykin, D.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2001-01
- Volume
- 119
- Issue
- 1
- Pages
- 8S-21S
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2125650394
- Cited by
- 1,804
- References
- 152
- FWCI
- 82.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.